Skip to main content
PLOS Medicine logoLink to PLOS Medicine
. 2012 Mar 5;9(3):10.1371/annotation/d3542745-d656-445b-842b-3d338a795bcc. doi: 10.1371/annotation/d3542745-d656-445b-842b-3d338a795bcc

Correction: Predicting Tumor Responses to Gefitinib and Erlotinib

Predicting Tumor Responses to Gefitinib and Erlotinib
PMCID: PMC3313822

An image that was published alongside another PLoS Medicine article (doi/10.1371/journal.pmed.0020024) and included in the shared PDF download here has been removed from the published PDF because of that image's copyright status.

Footnotes

No competing interests declared.


Articles from PLoS Medicine are provided here courtesy of PLOS

RESOURCES